abstract |
The present invention relates to a liver cancer marker that improves the accuracy of liver cancer diagnosis through a simple analysis using an overexpression phenomenon of Annexin 2 in the body fluid of a liver cancer patient, and a liver cancer diagnostic kit using the same. |